Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview Dow Down 0.54 Pct Sp 500 Flat Nasdaq Up 0.16 Pct 20260328 1 AI Data Centers Spark Power Crisis for 49000 California Households Gold Weakens as Feds Waller Signals Potential Rate Hike Amid Iran Conflict Energy Risks Trump Seeks Supreme Court Intervention to Halt TikTok Ban Potential Implications for Tech Sector Amazon UK Director Challenges Blame on Youth Unemployment Points to Education System Gap Lululemon Shares Gain as Company Reaches Proxy Settlement with Founder Chip Wilson SpaceX OpenAI and Anthropic IPOs Could Test Limits of AI Boom as Founders Vie for Wall Street Capital AERT Q1 2026 Earnings Positive EPS Reported Amid Steady Trading CNTA Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Flat PLBY Q1 2026 Earnings EPS Misses Estimates Amidst Ongoing Challenges CEPT Q1 2026 Earnings EPS Surges 96 Above Estimates Amid Investment Gains FIS Q1 2026 Earnings EPS Beat Cushions the Blow as Stock Slips Pathward Financial CASH Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly CapsoVision CV Holds Steady Near Key Support Amid Low Volatility IM Cannabis Corp IMCC Edges Higher Amid Tight Trading Range BHFAL Pushes Higher as Yield Appeal Holds Steady Grupo Cibest CIB Slides 13 ADR Tests Key Support as Sector Headwinds Persist Neptune Insurance Holdings NP Holds Steady Above Support Despite Thin Gains ILPT Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Discipline Amid Market Headwinds Precision BioSciences DTIL Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Stock Edges Higher ATS Q1 2026 Earnings EPS Beats Estimates by 924 Stock Rises 184 MNPR Q1 2026 Earnings NarrowerThanExpected Loss Reflects Controlled Spending Stock Edges Higher FSUN Q1 2026 Earnings EPS Falls Short of Analyst Expectations Shares Edge Lower Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline